CYPH
NASDAQCypherpunk Technologies Inc.
SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
News25/Ratings1
News · 26 weeks47+900%
2026-03-012026-08-23
Mix2290d
- Insider12(55%)
- SEC Filings6(27%)
- Other2(9%)
- Analyst1(5%)
- M&A1(5%)
Latest news
25 items- INSIDERSEC Form 4 filed by Head of Mining Zhang Kevin to satisfy withholding obligation4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERNew insider Zhang Kevin claimed ownership of 330,904 shares (SEC Form 3)3 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERChief Investment Officer Mcevoy William Patrick Iii exercised 16,570,852 in-the-money shares at a strike of $0.00 (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERLarge owner Winklevoss Capital Fund, Llc exercised 16,570,852 in-the-money shares at a strike of $0.00 (SEC Form 4)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Launches World's Largest Zcash Mining FleetEquity-based transaction with Winklevoss Capital activates 4.2 GSol/s of live, U.S.-based hashrate; approximately 18% of the Zcash network; Industry veteran Kevin Zhang joins as Head of MiningCAMBRIDGE, Mass., Aug. 18, 2026 /CNW/ -- Cypherpunk Technologies Inc. (NASDAQ:CYPH) ("Cypherpunk") today announced the launch of Cypherpunk Mining, which is now the largest Zcash mining fleet in the world, through a $33.33 million equity-based transaction with Winklevoss Capital. The fleet is online today, with approximately 4.2 GSol/s of Equihash hashrate deployed across the United States, which currently represents approximately 18% of the total Zcash network."Up until now, investors have had limited
- SECSEC Form 10-Q filed by Cypherpunk Technologies Inc.10-Q - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Reports Second Quarter 2026 Financial ResultsCAMBRIDGE, Mass., Aug. 12, 2026 /CNW/ -- Cypherpunk Technologies Inc., (NASDAQ:CYPH) ("Cypherpunk"), today reported financial results for the second quarter ended June 30, 2026."In the second quarter, Cypherpunk built upon the momentum established earlier this year through the disciplined execution of our Zcash digital asset treasury strategy, increasing our treasury holdings to 323,394.38 ZEC, and welcoming Dev Ojha, founder of Valar Group, as an Advisor," said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. "Our Leap Therapeutics subsidiary reached alignment with the FDA on a proposed Phase 3 trial in a DKK1-high, second-line, metastatic colorectal cancer population, with ob
- PRLeap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer ResearchPeer-reviewed analyses establish baseline plasma DKK1 as a continuous quantitative biomarker predicting deepening sirexatamab benefit in 2L mCRC patients In DKK1-high 2L mCRC patients, sirexatamab improved response, progression-free survival, and overall survival when added to bevacizumab and chemotherapyCAMBRIDGE, Mass., Aug. 12, 2026 /PRNewswire/ -- Leap Therapeutics, Inc., the biotechnology subsidiary of Cypherpunk Technologies Inc. (NASDAQ:CYPH), today announced the publication of results from the randomized Phase 2 DeFianCe study of sirexatamab (DKN-01), an anti-DKK1 monoclonal antibody, in Clinical Cancer Research.The publication, "Sirexatamab in Combination with Bevacizumab and Chemo
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- INSIDERSEC Form 4 filed by Director Richard Christian M (for withholding tax)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Oei Khing Djien (withholding obligation)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Dietz Thomas John (tax withholding)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Martin Patricia A. to cover taxes4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Li William (for tax liability)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by CEO,CFO,Pres.,GC,Treas.&Sec. Onsi Douglas E to satisfy withholding obligation4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Chief Investment Officer Mcevoy William Patrick Iii to satisfy withholding tax4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- INSIDERSEC Form 4 filed by Director Mashiach Nissim (withholding obligation)4 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Issuer)
- ANALYSTCantor Fitzgerald initiated coverage on Cypherpunk Technologies with a new price targetCantor Fitzgerald initiated coverage of Cypherpunk Technologies with a rating of Overweight and set a new price target of $0.90
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- SECSEC Form S-8 filed by Cypherpunk Technologies Inc.S-8 - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- SECSEC Form 8-K filed by Cypherpunk Technologies Inc.8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- SECCypherpunk Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CYPHERPUNK TECHNOLOGIES INC. (0001509745) (Filer)
- PRCypherpunk Technologies Reports First Quarter 2026 Financial ResultsCAMBRIDGE, Mass., May 14, 2026 /CNW/ -- Cypherpunk Technologies Inc., (NASDAQ:CYPH) ("Cypherpunk"), today reported financial results for the first quarter ended March 31, 2026."Since the start of 2026, Cypherpunk has advanced the mission to become a leading privacy technology company with a digital asset treasury strategy focused on Zcash by making our first privacy technology investment and increasing our treasury holdings to 314,185.70 ZEC," said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. "At AACR 2026, our Leap Therapeutics subsidiary presented a new DKK1 biomarker assay developed to support the selection of patients likely to benefit from sirexatamab therapy, along wi
CYPH FAQ
5 questionsWhere does CYPH stock trade?
Cypherpunk Technologies Inc. (CYPH) is listed on NASDAQ.What sector and industry is CYPH in?
Cypherpunk Technologies Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.What are analysts saying about CYPH?
Cypherpunk Technologies Inc. has had 1 recent analyst action on file. The most recent action was from Cantor Fitzgerald: Overweight with a $90.00 price target on 2026-07-01. Recent price targets cluster around $90.00.What companies are similar to CYPH?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare CYPH side-by-side with any of them on Quantisnow.How can I track CYPH on Quantisnow?
Quantisnow aggregates Cypherpunk Technologies Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CYPH to receive live email and push alerts on every new disclosure.